Hemolytic Anemia Due to Infection

Overview


Plain-Language Overview

Hemolytic anemia due to infection is a condition where the body's red blood cells are destroyed faster than they can be made, often because of an infection. This affects the blood and immune system, leading to symptoms like fatigue, pale skin, and rapid heartbeat. The infection can cause the immune system to mistakenly attack red blood cells or directly damage them. Common infections involved include certain bacteria, viruses, and parasites. This destruction reduces the oxygen-carrying capacity of the blood, which can cause weakness and shortness of breath. The condition can vary in severity depending on the infection and the individual's health. Prompt diagnosis is important to address the underlying infection and manage anemia.

Clinical Definition

Hemolytic anemia due to infection is characterized by premature destruction of red blood cells (RBCs) triggered by infectious agents. The core pathology involves increased RBC lysis either through direct pathogen-mediated damage, immune complex formation, or activation of the complement system. Common infectious causes include Plasmodium species (malaria), Clostridium perfringens, Mycoplasma pneumoniae, and viral infections such as Epstein-Barr virus. This condition leads to a decrease in circulating RBC mass, resulting in anemia, jaundice, and reticulocytosis. The hemolysis can be intravascular or extravascular, with clinical significance including potential for severe anemia, hemoglobinuria, and secondary complications like acute kidney injury. Recognition of infection-associated hemolysis is critical for targeted antimicrobial therapy and supportive care.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.